Divested Neometeoryl Transruminal & Oral Solution

41 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1460.0%

Death Rate

Active Ingredients

Divested Neometeoryl Transruminal & Oral Solution

Administration Routes

UnknownOralSubcutaneousOtherNasal

Species Affected

Dog 31

Horse 4

Cattle 4

Cat 2

Most Affected Breeds

Dachshund (unspecified) 6

Retriever - Labrador 5

Crossbred Equine/horse 4

Cattle (unknown) 4

Rottweiler 3

Terrier - Cairn 2

Maltese 2

Shepherd Dog - German 2

Beagle 2

Schnauzer (unspecified) 1

Most Reported Reactions

Vomiting 10

Diarrhoea 7

Death 6

Lack of efficacy (endoparasite) - heartworm 5

Lethargy (see also Central nervous system depression in 'Neurological') 5

Colic 4

Injection site oedema 4

Lack of efficacy - NOS 4

Lack of efficacy (bacteria) - NOS 4

Lack of efficacy (tick) 4

Pruritus 3

Seizure NOS 3

Outcome Breakdown

Outcome Unknown

14 (31.1%)

Recovered/Normal

13 (28.9%)

Ongoing

9 (20.0%)

Died

4 (8.9%)

Recovered with Sequela

3 (6.7%)

Euthanized

2 (4.4%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.